The SEB1741 Aptamer Is an Efficient Tool for Blocking CD4+ T Cell Activation Induced by Staphylococcal Enterotoxin B

Staphylococcal enterotoxin B (SEB) is a protein produced by <i>Staphylococcus aureus</i>, which is toxic to humans. It is well known for its ability to stimulate the exacerbated activation of proinflammatory CD4+ T cells (Th1 profile), and in vitro studies have been conducted to understa...

Full description

Bibliographic Details
Main Authors: Leslie Chavez-Galan, Andy Ruiz, Lucero A. Ramón-Luing, Alejandro Escamilla-Gutiérrez, Anahí Sánchez-Monciváis, Brenda Tecuatzi-Cadena, Karen Medina-Quero, María Guadalupe Córdova-Espinoza
Format: Article
Language:English
Published: MDPI AG 2023-04-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/28/8/3480
_version_ 1797604100961992704
author Leslie Chavez-Galan
Andy Ruiz
Lucero A. Ramón-Luing
Alejandro Escamilla-Gutiérrez
Anahí Sánchez-Monciváis
Brenda Tecuatzi-Cadena
Karen Medina-Quero
María Guadalupe Córdova-Espinoza
author_facet Leslie Chavez-Galan
Andy Ruiz
Lucero A. Ramón-Luing
Alejandro Escamilla-Gutiérrez
Anahí Sánchez-Monciváis
Brenda Tecuatzi-Cadena
Karen Medina-Quero
María Guadalupe Córdova-Espinoza
author_sort Leslie Chavez-Galan
collection DOAJ
description Staphylococcal enterotoxin B (SEB) is a protein produced by <i>Staphylococcus aureus</i>, which is toxic to humans. It is well known for its ability to stimulate the exacerbated activation of proinflammatory CD4+ T cells (Th1 profile), and in vitro studies have been conducted to understand its mechanism of action and its potential use as an immune therapy. However, the efficiency of the SEB1741 aptamer in blocking SEB has not been experimentally demonstrated. Methods: Enrichment CD4+ T cells were stimulated with SEB, and as a blocker, we used the SEB1741 aptamer, which was previously synthesised by an “in silico” analysis, showing high affinity and specificity to SEB. The efficiency of the SEB1741 aptamer in blocking CD4+ T cell activation was compared with that of an anti-SEB monoclonal antibody. Flow cytometry and Bio-Plex were used to evaluate the T-cell function. Results: In vitro, SEB induced the activation of CD4+ T cells and favoured a Th1 profile; however, the SEB1741 aptamer was highly efficient in decreasing the frequency of CD4+ T cells positive to ki-67 and CD69 cells, this means that proliferation and activation of CD4+ T cells was decreased. Moreover, the production of interleukin 2 (IL-2) and interferon-gamma (IFN-γ) was affected, suggesting that the Th1 profile is not present when the SEB1441 aptamer is used. Thus, the SEB1741 function was similar to that of anti-SEB. Conclusions: The SEB1741 aptamer is a valuable tool for blocking CD4+ T cell activation and the subsequent release of proinflammatory cytokines by SEB stimulation.
first_indexed 2024-03-11T04:41:33Z
format Article
id doaj.art-751ef28310f0487fad5cdc8862ea7d97
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-03-11T04:41:33Z
publishDate 2023-04-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-751ef28310f0487fad5cdc8862ea7d972023-11-17T20:39:33ZengMDPI AGMolecules1420-30492023-04-01288348010.3390/molecules28083480The SEB1741 Aptamer Is an Efficient Tool for Blocking CD4+ T Cell Activation Induced by Staphylococcal Enterotoxin BLeslie Chavez-Galan0Andy Ruiz1Lucero A. Ramón-Luing2Alejandro Escamilla-Gutiérrez3Anahí Sánchez-Monciváis4Brenda Tecuatzi-Cadena5Karen Medina-Quero6María Guadalupe Córdova-Espinoza7Laboratory of Integrative Immunology, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City 14080, MexicoLaboratory of Integrative Immunology, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City 14080, MexicoLaboratory of Integrative Immunology, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City 14080, MexicoLaboratory of Medical Bacteriology, Department of Microbiology, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Mexico City 11350, MexicoLaboratory of Immunology, Escuela Militar de Graduados de Sanidad, SEDENA, Mexico City 11200, MexicoLaboratory of Immunology, Escuela Militar de Graduados de Sanidad, SEDENA, Mexico City 11200, MexicoLaboratory of Immunology, Escuela Militar de Graduados de Sanidad, SEDENA, Mexico City 11200, MexicoLaboratory of Medical Bacteriology, Department of Microbiology, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Mexico City 11350, MexicoStaphylococcal enterotoxin B (SEB) is a protein produced by <i>Staphylococcus aureus</i>, which is toxic to humans. It is well known for its ability to stimulate the exacerbated activation of proinflammatory CD4+ T cells (Th1 profile), and in vitro studies have been conducted to understand its mechanism of action and its potential use as an immune therapy. However, the efficiency of the SEB1741 aptamer in blocking SEB has not been experimentally demonstrated. Methods: Enrichment CD4+ T cells were stimulated with SEB, and as a blocker, we used the SEB1741 aptamer, which was previously synthesised by an “in silico” analysis, showing high affinity and specificity to SEB. The efficiency of the SEB1741 aptamer in blocking CD4+ T cell activation was compared with that of an anti-SEB monoclonal antibody. Flow cytometry and Bio-Plex were used to evaluate the T-cell function. Results: In vitro, SEB induced the activation of CD4+ T cells and favoured a Th1 profile; however, the SEB1741 aptamer was highly efficient in decreasing the frequency of CD4+ T cells positive to ki-67 and CD69 cells, this means that proliferation and activation of CD4+ T cells was decreased. Moreover, the production of interleukin 2 (IL-2) and interferon-gamma (IFN-γ) was affected, suggesting that the Th1 profile is not present when the SEB1441 aptamer is used. Thus, the SEB1741 function was similar to that of anti-SEB. Conclusions: The SEB1741 aptamer is a valuable tool for blocking CD4+ T cell activation and the subsequent release of proinflammatory cytokines by SEB stimulation.https://www.mdpi.com/1420-3049/28/8/3480SEBanti-SEBSEB1741 aptamerCD4+ T cellsinflammation
spellingShingle Leslie Chavez-Galan
Andy Ruiz
Lucero A. Ramón-Luing
Alejandro Escamilla-Gutiérrez
Anahí Sánchez-Monciváis
Brenda Tecuatzi-Cadena
Karen Medina-Quero
María Guadalupe Córdova-Espinoza
The SEB1741 Aptamer Is an Efficient Tool for Blocking CD4+ T Cell Activation Induced by Staphylococcal Enterotoxin B
Molecules
SEB
anti-SEB
SEB1741 aptamer
CD4+ T cells
inflammation
title The SEB1741 Aptamer Is an Efficient Tool for Blocking CD4+ T Cell Activation Induced by Staphylococcal Enterotoxin B
title_full The SEB1741 Aptamer Is an Efficient Tool for Blocking CD4+ T Cell Activation Induced by Staphylococcal Enterotoxin B
title_fullStr The SEB1741 Aptamer Is an Efficient Tool for Blocking CD4+ T Cell Activation Induced by Staphylococcal Enterotoxin B
title_full_unstemmed The SEB1741 Aptamer Is an Efficient Tool for Blocking CD4+ T Cell Activation Induced by Staphylococcal Enterotoxin B
title_short The SEB1741 Aptamer Is an Efficient Tool for Blocking CD4+ T Cell Activation Induced by Staphylococcal Enterotoxin B
title_sort seb1741 aptamer is an efficient tool for blocking cd4 t cell activation induced by staphylococcal enterotoxin b
topic SEB
anti-SEB
SEB1741 aptamer
CD4+ T cells
inflammation
url https://www.mdpi.com/1420-3049/28/8/3480
work_keys_str_mv AT lesliechavezgalan theseb1741aptamerisanefficienttoolforblockingcd4tcellactivationinducedbystaphylococcalenterotoxinb
AT andyruiz theseb1741aptamerisanefficienttoolforblockingcd4tcellactivationinducedbystaphylococcalenterotoxinb
AT luceroaramonluing theseb1741aptamerisanefficienttoolforblockingcd4tcellactivationinducedbystaphylococcalenterotoxinb
AT alejandroescamillagutierrez theseb1741aptamerisanefficienttoolforblockingcd4tcellactivationinducedbystaphylococcalenterotoxinb
AT anahisanchezmoncivais theseb1741aptamerisanefficienttoolforblockingcd4tcellactivationinducedbystaphylococcalenterotoxinb
AT brendatecuatzicadena theseb1741aptamerisanefficienttoolforblockingcd4tcellactivationinducedbystaphylococcalenterotoxinb
AT karenmedinaquero theseb1741aptamerisanefficienttoolforblockingcd4tcellactivationinducedbystaphylococcalenterotoxinb
AT mariaguadalupecordovaespinoza theseb1741aptamerisanefficienttoolforblockingcd4tcellactivationinducedbystaphylococcalenterotoxinb
AT lesliechavezgalan seb1741aptamerisanefficienttoolforblockingcd4tcellactivationinducedbystaphylococcalenterotoxinb
AT andyruiz seb1741aptamerisanefficienttoolforblockingcd4tcellactivationinducedbystaphylococcalenterotoxinb
AT luceroaramonluing seb1741aptamerisanefficienttoolforblockingcd4tcellactivationinducedbystaphylococcalenterotoxinb
AT alejandroescamillagutierrez seb1741aptamerisanefficienttoolforblockingcd4tcellactivationinducedbystaphylococcalenterotoxinb
AT anahisanchezmoncivais seb1741aptamerisanefficienttoolforblockingcd4tcellactivationinducedbystaphylococcalenterotoxinb
AT brendatecuatzicadena seb1741aptamerisanefficienttoolforblockingcd4tcellactivationinducedbystaphylococcalenterotoxinb
AT karenmedinaquero seb1741aptamerisanefficienttoolforblockingcd4tcellactivationinducedbystaphylococcalenterotoxinb
AT mariaguadalupecordovaespinoza seb1741aptamerisanefficienttoolforblockingcd4tcellactivationinducedbystaphylococcalenterotoxinb